NCT03868748View on ClinicalTrials.gov

Safety Evaluation of β-arbutin in Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Beta-arbutin

Beta-arbutin capsules

OTHER

Placebo

Placebo capsules containing non-medicinal ingredients

Trial Locations (2)

N6A 4V2

St Joseph's Health Care London, St. Joseph's Hospital, London

N6A5R8

KGK Science, London

All Listed Sponsors
collaborator

Canadian Glycomics Network (GlycoNet)

UNKNOWN

lead

SP Nutraceuticals Inc.

INDUSTRY

NCT03868748 - Safety Evaluation of β-arbutin in Healthy Human Subjects | Biotech Hunter | Biotech Hunter